SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-018338
Filing Date
2020-08-13
Accepted
2020-08-13 16:30:47
Documents
10
Period of Report
2020-08-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nt10013643x7_form8k.htm 8-K 27288
2 EXHIBIT 1.1 nt10013643x7_ex1-1.htm EX-1.1 183668
3 EXHIBIT 5.1 nt10013643x7_ex5-1.htm EX-5.1 8280
4 EXHIBIT 99.1 nt10013643x7_ex99-1.htm EX-99.1 8667
5 EXHIBIT 99.2 nt10013643x7_ex99-2.htm EX-99.2 8396
6 EXHIBIT 99.3 nt10013643x7_ex99-3.htm EX-99.3 8381
7 nt10013643x7_ex99-3image01.jpg GRAPHIC 5848
8 nt10013643x7_image01.jpg GRAPHIC 2894
9 nt10013643x7_image02.jpg GRAPHIC 9229
10 nt10013643x7_image03.jpg GRAPHIC 5368
  Complete submission text file 0001140361-20-018338.txt   278620
Mailing Address 25B VREELAND ROAD FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 201099746
SIC: 2834 Pharmaceutical Preparations